View in EDS HTML Full Text PDF Full Text

Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies.

Saved in:
Bibliographic Details
Title: Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies.
Authors: Burón M; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain., Etxebarria A; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain., Álvarez M; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain., Romayor I; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Eguizabal C; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain.
Source: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2563099. Date of Electronic Publication: 2025 Sep 25.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40996824
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burón+M%22">Burón M</searchLink>; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.<br /><searchLink fieldCode="AU" term="%22Etxebarria+A%22">Etxebarria A</searchLink>; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez+M%22">Álvarez M</searchLink>; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Romayor+I%22">Romayor I</searchLink>; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Eguizabal+C%22">Eguizabal C</searchLink>; Cell Therapy, Stem Cells and Tissues Group, Biobizkaia Health Research Institute, Barakaldo, Spain.; Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.; Red Española de Terapias Avanzadas (TERAV and TERAV+), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2563099. <i>Date of Electronic Publication: </i>2025 Sep 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40996824
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2025.2563099
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2563099
    Titles:
      – TitleFull: Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burón M
      – PersonEntity:
          Name:
            NameFull: Etxebarria A
      – PersonEntity:
          Name:
            NameFull: Álvarez M
      – PersonEntity:
          Name:
            NameFull: Romayor I
      – PersonEntity:
          Name:
            NameFull: Eguizabal C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1